Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Treasury Shares (2023 - 2025)

Camp4 Therapeutics (CAMP) has disclosed Treasury Shares for 3 consecutive years, with $4277.0 as the latest value for Q1 2025.

  • Quarterly Treasury Shares changed N/A to $4277.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $4277.0 through Mar 2025, changed N/A year-over-year, with the annual reading at $15943.0 for FY2024, 78.53% down from the prior year.
  • Treasury Shares hit $4277.0 in Q1 2025 for Camp4 Therapeutics, down from $15943.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $74243.0 in Q4 2023 to a low of $4277.0 in Q1 2025.
  • Historically, Treasury Shares has averaged $31267.5 across 3 years, with a median of $23275.0 in 2024.
  • Biggest YoY gain for Treasury Shares was 78.53% in 2024; the steepest drop was 78.53% in 2024.
  • Year by year, Treasury Shares stood at $74243.0 in 2023, then crashed by 78.53% to $15943.0 in 2024, then tumbled by 73.17% to $4277.0 in 2025.
  • Business Quant data shows Treasury Shares for CAMP at $4277.0 in Q1 2025, $15943.0 in Q4 2024, and $30607.0 in Q3 2024.